Pre-Clinical Development of IK-101, an Orally available Small Molecule Inhibitor of IP6K for the Treatment of Obesity and MASH
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
InoKare Therapeutics, Inc
Award Date
Award Amount
300,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Sanjeev Munshi
Fiscal Year
2025
Region
Research Triangle
Project Description:
InoKare Therapeutics of Durham recieved $350,000 for pre-clinical development of an orally availble small molecule treatment for the treatment of obesity and MASH.